Triangle Plant Sciences (“TPS”), a division of Verdesian Life Sciences of Cary, NC, has announced a partnership with MustGrow Biologics Corp. (CSE:MGRO) (“MustGrow”) of Saskatoon, SK, to offer exclusive Canada and global access to TPS’s TP-1000, the first product in a suite of researched hydroponic technology offerings.
“This is an exciting time to launch a TPS and MustGrow partnership that will deliver TPS’s best-in-class nutrient technology solutions for MustGrow’s high-value hydroponic applications, including cannabis in production legal geographies. TP-1000 is the first offering in a high-performing suite of technologies that improve nutrient utilization in support of early growth and optimal flowering,” said Nick Favret, Senior Product Director, Triangle Plant Sciences. “Third party indoor trials have demonstrated excellent performance in hydroponic cannabis applications, with significant increases in terpene, and tetrahydrocannabinol (THC) concentration. TP-1000’s unique formulation facilitates rapid plant nutrient uptake for optimal metabolism, growth, crop quality and yield.”
Through this partnership, TP-1000 will be made commercially available exclusively through MustGrow in Canada, and MustGrow will also distribute in key registered markets globally.
“We are thrilled to enter into a partnership with Triangle Plant Sciences,” said Colin Bletsky, Chief Operations Officer, MustGrow. “The vision of TPS aligns perfectly to that of MustGrow, and we look forward to working hand-in-hand to offer the TPS suite of hydroponic products throughout Canada and, eventually, the world.”
Verdesian Life Sciences enables a sustainable future for farmers through nutrient use efficiency (NUE™). Grown from the ground up in 2012, Verdesian Life Sciences offers farmers and growers biological, nutritional, seed treatment, and inoculant technologies that maximize performance on high-value row crops and specialty crops as well as turf and ornamental plants. As a 4R Nutrient Stewardship Partner, Verdesian is committed to researching and developing environmentally- and financially-sustainable products. Further information about Verdesian is available at www.vlsci.com. Verdesian offers a variety of best-in-class of plant nutrition, for a variety of plant types and needs; hydroponics is a natural extension of our capabilities.
MustGrow is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, MustGrow has designed a United States EPA-approved organic solution that uses the mustard seed’s natural defence mechanisms to protect plants from pests and diseases. Approximately $9 million has previously been spent and 110 independent tests completed, validating MustGrow’s remarkably safe and effective granular product.
MustGrow’s granular product is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s PMRA (Pest Management Regulatory Agency) as a fruit, vegetable, turf and ornamental biopesticide and biofertilizer.
In cannabis, MustGrow is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. MustGrow is positioning its signature product as an effective pre-plant soil treatment, reducing the chance for any added soil introduced to a greenhouse to bring in pests or diseases. MustGrow expects its biopesticide and biofertilizer will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops.
The Company has 25.0 million basic common shares issued and outstanding and 36.9 million on a fully-diluted basis. For further details, including MustGrow’s corporate presentation, please visit www.mustgrow.ca.
ON BEHALF OF THE BOARD
Director & CEO
Always read and follow label use directions. © 2019 Verdesian Life Sciences. All rights reserved.
Certain statements included in this website constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”.
Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow.
These risks are described in more detail in MustGrow’s Prospectus and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities and available at www.sedar.com. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or